For the year ending 2025-12-31, RPRX has $19,620,780K in assets. $9,905,841K in debts. $618,696K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 618,696 | 929,026 | 477,010 | 1,710,751 |
| Marketable securities | - | - | 0 | 24,421 |
| Financial royalty assets | 854,386 | 783,770 | 738,438 | 691,319 |
| Accrued royalty receivable | - | - | 14,242 | 16,830 |
| Available for sale debt securities | 18,800 | 58,200 | 18,300 | 1,300 |
| Other royalty income receivable | 29,316 | 26,956 | 22,405 | 19,767 |
| Other current assets | 6,893 | 4,187 | 3,798 | 90,520 |
| Total current assets | 1,528,091 | 1,802,139 | 1,274,193 | 2,554,908 |
| Financial royalty assets, net | 16,208,482 | 15,127,158 | 14,088,655 | 13,493,106 |
| Intangible royalty assets, net | - | - | - | 0 |
| Equity securities | 171,312 | 186,960 | 199,487 | 112,348 |
| Available for sale debt securities | 419,000 | 693,500 | 437,100 | 226,300 |
| Equity method investments | 289,968 | 379,424 | 375,894 | 397,175 |
| Goodwill | 924,634 | - | - | - |
| Other assets | 79,293 | 33,534 | 6,522 | 29,629 |
| Total assets | 19,620,780 | 18,222,715 | 16,381,851 | 16,813,466 |
| Distributions payable to legacy non-controlling interests | 72,825 | 75,811 | 83,155 | 94,803 |
| Accounts payable and accrued expenses | 19,404 | 13,370 | 15,165 | 7,906 |
| Interest payable | 110,818 | 98,062 | 51,682 | 54,162 |
| Current portion of long-term debt | 380,000 | 997,773 | 0 | 997,512 |
| Other current liabilities | 53,164 | 68,600 | 11,375 | 12,400 |
| Total current liabilities | 636,211 | 1,253,616 | 161,377 | 1,166,783 |
| Long-term debt | 8,570,917 | 6,614,653 | 6,135,285 | 6,118,810 |
| Accrued compensation liabilities | 577,870 | - | - | - |
| Other liabilities | 120,843 | 12,080 | 900 | 2,500 |
| Total liabilities | 9,905,841 | 7,880,349 | 6,297,562 | 7,288,093 |
| Common stock-Common Class A | 43 | 45 | 45 | 44 |
| Common stock-Common Class B | 0 | 0 | 0 | 0 |
| Common stock-Class RRedeemable Stock | 63 | 63 | 63 | 63 |
| Additional paid-in capital | 4,123,088 | 4,103,482 | 4,011,435 | 3,666,160 |
| Retained earnings | 2,356,318 | 2,845,653 | 2,517,583 | 1,964,689 |
| Non-controlling interests | 3,238,039 | 3,395,785 | 3,557,792 | 3,897,223 |
| Accumulated other comprehensive income | - | - | - | 0 |
| Treasury interests | 2,612 | 2,662 | 2,629 | 2,806 |
| Total shareholders equity | 9,714,939 | 10,342,366 | 10,084,289 | 9,525,373 |
| Total liabilities and shareholders equity | 19,620,780 | 18,222,715 | 16,381,851 | 16,813,466 |
Royalty Pharma plc (RPRX)
Royalty Pharma plc (RPRX)